Skip to main content
Skip to navigation

Commission Regulation (EC) No 847/2000Show full title

Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts ‘similar medicinal product’ and ‘clinical superiority’ (revoked)

F1Article 2U.K.Criteria for designation

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Textual Amendments applied to the whole legislation

F1Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(g) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)